Breaking News Instant updates and real-time market news.

ALKS

Alkermes

$45.06

1.29 (2.95%)

07:34
08/07/18
08/07
07:34
08/07/18
07:34

Alkermes initiated with a Hold at Stifel

Stifel analyst Paul Matteis initiated coverage of Alkermes with a Hold rating and a $45 price target, stating that he has a more positive than consensus view on Aristada for schizophrenia and BIIB098 for Multiple Sclerosis, but a more cautious view on Vivitrol for addiction. While he is "cautiously optimistic" on ALKS3831 data in schizophrenia due in the fourth quarter, he is pessimistic on the odds of FDA approval for ALKS5461 for treatment-resistant depression without another positive clinical study, Matteis tells investors.

  • 08

    Aug

  • 04

    Sep

  • 31

    Jan

ALKS Alkermes
$45.06

1.29 (2.95%)

06/22/18
RILY
06/22/18
NO CHANGE
RILY
Buy
Alkermes thesis unchanged despite recent selloff, says B. Riley FBR
B. Riley FBR analyst David Buck says the recent pullback in shares of Alkermes does not change his Buy thesis as the company's Vivitrol franchise continues to grow. The analyst keeps a Buy rating on the shares with a $60 price target.
07/20/18
RILY
07/20/18
NO CHANGE
Target $60
RILY
Buy
Alkermes remains a favored stock for second half at B. Riley FBR
B. Riley FBR analyst David Buck says Alkermes remains one of his firm's "Favorite Five stocks" for the second half of 2018. The analyst expects the company to post 31% year-over-year revenue growth in Q2 and for management to update investors on oncology pipeline candidate ALKS 4230. Buck keeps a Buy rating on Alkermes with a $60 price target.
07/27/18
CANT
07/27/18
NO CHANGE
Target $46
CANT
Neutral
Alkermes story still about ALKS 5461 approvability, says Cantor Fitzgerald
Cantor Fitzgerald analyst William Tanner reiterates a Neutral rating on Alkermes with a $46 price target following yesterday's Q2 results. FDA approval of ALKS 5461 is critical to the company's long-term prospects, Tanner tells investors in a research note. He maintains the view that "approval is far from clear-cut." The analyst calls the FDA advisory panel in Q4 a "major event." With an FDA action date of January 31, 2019, there could be some time to address deficiencies, if needed, the analyst writes. Tanner believes that with two of the Phase 3 studies failing to meet the primary endpoint, regulatory issues "could be more complicated than simply viewing all of the data in aggregate."
08/06/18
STFL
08/06/18
INITIATION
STFL
Hold
Alkermes initiated with a Hold at Stifel

TODAY'S FREE FLY STORIES

FB

Facebook

$142.51

0.99 (0.70%)

15:11
11/13/18
11/13
15:11
11/13/18
15:11
Hot Stocks
Facebook took down 141 accounts following FBI tip »

Facebook said that last…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

THC

Tenet

$23.33

-2.39 (-9.29%)

15:10
11/13/18
11/13
15:10
11/13/18
15:10
Options
$2M call buy in Tenet Healthcare as shares lose 9% »

$2M call buy in Tenet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

15:10
11/13/18
11/13
15:10
11/13/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

AMC

AMC Entertainment

$15.49

0.3 (1.98%)

15:08
11/13/18
11/13
15:08
11/13/18
15:08
Recommendations
AMC Entertainment analyst commentary  »

AMC seeing success with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 04

    Dec

AAWW

Atlas Air

$55.19

2.03 (3.82%)

15:05
11/13/18
11/13
15:05
11/13/18
15:05
Hot Stocks
Atlas Air, Southern Air announce pathway program agreement with Ameriflight »

Atlas Air Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$90.46

1.99 (2.25%)

15:04
11/13/18
11/13
15:04
11/13/18
15:04
Options
Wix.com options imply 18.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

ECA

Encana

$8.10

-0.31 (-3.69%)

15:00
11/13/18
11/13
15:00
11/13/18
15:00
Options
Encana option volume hits year high as shares touch year lows »

Encana option volume hits…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

$63.45

-0.35 (-0.55%)

, AAPL

Apple

$193.43

-0.725 (-0.37%)

14:51
11/13/18
11/13
14:51
11/13/18
14:51
Recommendations
Qorvo, Apple, Lumentum, Skyworks, Cirrus Logic, Broadcom analyst commentary  »

After Qorvo warns, MKM…

QRVO

Qorvo

$63.45

-0.35 (-0.55%)

AAPL

Apple

$193.43

-0.725 (-0.37%)

LITE

Lumentum

$38.92

1.415 (3.77%)

SWKS

Skyworks

$72.16

-0.61 (-0.84%)

CRUS

Cirrus Logic

$37.63

1.99 (5.58%)

AVGO

Broadcom

$224.39

0.84 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 19

    Nov

  • 06

    Dec

QRVO

Qorvo

$63.36

-0.44 (-0.69%)

, AAPL

Apple

$193.50

-0.655 (-0.34%)

14:51
11/13/18
11/13
14:51
11/13/18
14:51
Recommendations
Qorvo, Apple analyst commentary  »

JPMorgan sees…

QRVO

Qorvo

$63.36

-0.44 (-0.69%)

AAPL

Apple

$193.50

-0.655 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

AMRS

Amyris

$6.05

0.19 (3.24%)

14:49
11/13/18
11/13
14:49
11/13/18
14:49
Options
Amyris options imply 19.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BA

Boeing

$347.91

-9.02 (-2.53%)

14:46
11/13/18
11/13
14:46
11/13/18
14:46
Periodicals
Pilots claim Boeing Lion Air crash linked to improper training, FT reports »

Pilot associations said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$193.31

-0.845 (-0.44%)

14:45
11/13/18
11/13
14:45
11/13/18
14:45
Technical Analysis
Technical Take: Apple moves lower after rally fails »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

XLK

Technology Select Sector SPDR

$67.49

0.08 (0.12%)

14:40
11/13/18
11/13
14:40
11/13/18
14:40
Options
Aggressive call buying in SPDR Tech Fund »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

, AAPL

Apple

$192.80

-1.355 (-0.70%)

14:37
11/13/18
11/13
14:37
11/13/18
14:37
Recommendations
Qorvo, Apple analyst commentary  »

Qorvo price target…

QRVO

Qorvo

AAPL

Apple

$192.80

-1.355 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

TEUM

Pareteum

$1.87

-0.26 (-12.21%)

, IPAS

iPass

$1.14

(0.00%)

14:37
11/13/18
11/13
14:37
11/13/18
14:37
Recommendations
Pareteum, iPass analyst commentary  »

Pareteum price target…

TEUM

Pareteum

$1.87

-0.26 (-12.21%)

IPAS

iPass

$1.14

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

CF

CF Industries

$50.26

-1.03 (-2.01%)

14:35
11/13/18
11/13
14:35
11/13/18
14:35
Options
CF Industries put volume heavy and directionally bearish »

Bearish flow noted in CF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

LVS

Las Vegas Sands

$51.96

0.995 (1.95%)

14:25
11/13/18
11/13
14:25
11/13/18
14:25
Options
Las Vegas Sands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
11/13/18
11/13
14:25
11/13/18
14:25
General news
Treasury Action: yields remained remained lower »

Treasury Action: yields…

VOYA

Voya Financial

$45.49

0.905 (2.03%)

14:24
11/13/18
11/13
14:24
11/13/18
14:24
Recommendations
Voya Financial analyst commentary  »

Voya Financial updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/13/18
11/13
14:17
11/13/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLDP

Ballard Power

$3.07

0.11 (3.72%)

14:16
11/13/18
11/13
14:16
11/13/18
14:16
Hot Stocks
Ballard Power announces closing of strategic collaboration with Weichai Power »

Ballard Power Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/13/18
11/13
14:16
11/13/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:15
11/13/18
11/13
14:15
11/13/18
14:15
General news
U.S. Treasury budget deficit widened to $100 B »

U.S. Treasury budget…

APTI

Apptio

$37.76

0.12 (0.32%)

14:10
11/13/18
11/13
14:10
11/13/18
14:10
Options
Aptio attracts call buying after reports of takeover interest »

Aptio attracts call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

14:10
11/13/18
11/13
14:10
11/13/18
14:10
General news
U.S. Treasury budget preview: »

U.S. Treasury budget…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.